Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Biomarker Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Urine
1.2.3 Blood
1.2.4 Serum
1.3 Market by Application
1.3.1 Global Prostate Cancer Biomarker Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Biomarker Market Perspective (2018-2033)
2.2 Prostate Cancer Biomarker Growth Trends by Region
2.2.1 Global Prostate Cancer Biomarker Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Prostate Cancer Biomarker Historic Market Size by Region (2018-2023)
2.2.3 Prostate Cancer Biomarker Forecasted Market Size by Region (2024-2033)
2.3 Prostate Cancer Biomarker Market Dynamics
2.3.1 Prostate Cancer Biomarker Industry Trends
2.3.2 Prostate Cancer Biomarker Market Drivers
2.3.3 Prostate Cancer Biomarker Market Challenges
2.3.4 Prostate Cancer Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Biomarker Players by Revenue
3.1.1 Global Top Prostate Cancer Biomarker Players by Revenue (2018-2023)
3.1.2 Global Prostate Cancer Biomarker Revenue Market Share by Players (2018-2023)
3.2 Global Prostate Cancer Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Biomarker Revenue
3.4 Global Prostate Cancer Biomarker Market Concentration Ratio
3.4.1 Global Prostate Cancer Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Biomarker Revenue in 2022
3.5 Prostate Cancer Biomarker Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Biomarker Product Solution and Service
3.7 Date of Enter into Prostate Cancer Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Biomarker Breakdown Data by Type
4.1 Global Prostate Cancer Biomarker Historic Market Size by Type (2018-2023)
4.2 Global Prostate Cancer Biomarker Forecasted Market Size by Type (2024-2033)
5 Prostate Cancer Biomarker Breakdown Data by Application
5.1 Global Prostate Cancer Biomarker Historic Market Size by Application (2018-2023)
5.2 Global Prostate Cancer Biomarker Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Prostate Cancer Biomarker Market Size (2018-2033)
6.2 North America Prostate Cancer Biomarker Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Prostate Cancer Biomarker Market Size by Country (2018-2023)
6.4 North America Prostate Cancer Biomarker Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Cancer Biomarker Market Size (2018-2033)
7.2 Europe Prostate Cancer Biomarker Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Prostate Cancer Biomarker Market Size by Country (2018-2023)
7.4 Europe Prostate Cancer Biomarker Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Biomarker Market Size (2018-2033)
8.2 Asia-Pacific Prostate Cancer Biomarker Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Prostate Cancer Biomarker Market Size by Region (2018-2023)
8.4 Asia-Pacific Prostate Cancer Biomarker Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Cancer Biomarker Market Size (2018-2033)
9.2 Latin America Prostate Cancer Biomarker Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Prostate Cancer Biomarker Market Size by Country (2018-2023)
9.4 Latin America Prostate Cancer Biomarker Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Biomarker Market Size (2018-2033)
10.2 Middle East & Africa Prostate Cancer Biomarker Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Prostate Cancer Biomarker Market Size by Country (2018-2023)
10.4 Middle East & Africa Prostate Cancer Biomarker Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Prostate Cancer Biomarker Introduction
11.1.4 Thermo Fisher Scientific Revenue in Prostate Cancer Biomarker Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 QIAGEN
11.2.1 QIAGEN Company Detail
11.2.2 QIAGEN Business Overview
11.2.3 QIAGEN Prostate Cancer Biomarker Introduction
11.2.4 QIAGEN Revenue in Prostate Cancer Biomarker Business (2018-2023)
11.2.5 QIAGEN Recent Development
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Detail
11.3.2 Roche Diagnostics Business Overview
11.3.3 Roche Diagnostics Prostate Cancer Biomarker Introduction
11.3.4 Roche Diagnostics Revenue in Prostate Cancer Biomarker Business (2018-2023)
11.3.5 Roche Diagnostics Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Detail
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Prostate Cancer Biomarker Introduction
11.4.4 Beckman Coulter Revenue in Prostate Cancer Biomarker Business (2018-2023)
11.4.5 Beckman Coulter Recent Development
11.5 Myriad Genetics
11.5.1 Myriad Genetics Company Detail
11.5.2 Myriad Genetics Business Overview
11.5.3 Myriad Genetics Prostate Cancer Biomarker Introduction
11.5.4 Myriad Genetics Revenue in Prostate Cancer Biomarker Business (2018-2023)
11.5.5 Myriad Genetics Recent Development
11.6 Sanofi-Aventis
11.6.1 Sanofi-Aventis Company Detail
11.6.2 Sanofi-Aventis Business Overview
11.6.3 Sanofi-Aventis Prostate Cancer Biomarker Introduction
11.6.4 Sanofi-Aventis Revenue in Prostate Cancer Biomarker Business (2018-2023)
11.6.5 Sanofi-Aventis Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Prostate Cancer Biomarker Introduction
11.7.4 Pfizer Revenue in Prostate Cancer Biomarker Business (2018-2023)
11.7.5 Pfizer Recent Development
11.8 MDx Health
11.8.1 MDx Health Company Detail
11.8.2 MDx Health Business Overview
11.8.3 MDx Health Prostate Cancer Biomarker Introduction
11.8.4 MDx Health Revenue in Prostate Cancer Biomarker Business (2018-2023)
11.8.5 MDx Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Prostate Cancer Biomarker Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Urine
Table 3. Key Players of Blood
Table 4. Key Players of Serum
Table 5. Global Prostate Cancer Biomarker Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Prostate Cancer Biomarker Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Prostate Cancer Biomarker Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Prostate Cancer Biomarker Market Share by Region (2018-2023)
Table 9. Global Prostate Cancer Biomarker Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Prostate Cancer Biomarker Market Share by Region (2024-2033)
Table 11. Prostate Cancer Biomarker Market Trends
Table 12. Prostate Cancer Biomarker Market Drivers
Table 13. Prostate Cancer Biomarker Market Challenges
Table 14. Prostate Cancer Biomarker Market Restraints
Table 15. Global Prostate Cancer Biomarker Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Prostate Cancer Biomarker Market Share by Players (2018-2023)
Table 17. Global Top Prostate Cancer Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Biomarker as of 2022)
Table 18. Ranking of Global Top Prostate Cancer Biomarker Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Prostate Cancer Biomarker Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Prostate Cancer Biomarker Product Solution and Service
Table 22. Date of Enter into Prostate Cancer Biomarker Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Prostate Cancer Biomarker Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Prostate Cancer Biomarker Revenue Market Share by Type (2018-2023)
Table 26. Global Prostate Cancer Biomarker Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Prostate Cancer Biomarker Revenue Market Share by Type (2024-2033)
Table 28. Global Prostate Cancer Biomarker Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Prostate Cancer Biomarker Revenue Market Share by Application (2018-2023)
Table 30. Global Prostate Cancer Biomarker Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Prostate Cancer Biomarker Revenue Market Share by Application (2024-2033)
Table 32. North America Prostate Cancer Biomarker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Prostate Cancer Biomarker Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Prostate Cancer Biomarker Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Prostate Cancer Biomarker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Prostate Cancer Biomarker Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Prostate Cancer Biomarker Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Prostate Cancer Biomarker Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Prostate Cancer Biomarker Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Prostate Cancer Biomarker Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Prostate Cancer Biomarker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Prostate Cancer Biomarker Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Prostate Cancer Biomarker Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Prostate Cancer Biomarker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Prostate Cancer Biomarker Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Prostate Cancer Biomarker Market Size by Country (2024-2033) & (US$ Million)
Table 47. Thermo Fisher Scientific Company Detail
Table 48. Thermo Fisher Scientific Business Overview
Table 49. Thermo Fisher Scientific Prostate Cancer Biomarker Product
Table 50. Thermo Fisher Scientific Revenue in Prostate Cancer Biomarker Business (2018-2023) & (US$ Million)
Table 51. Thermo Fisher Scientific Recent Development
Table 52. QIAGEN Company Detail
Table 53. QIAGEN Business Overview
Table 54. QIAGEN Prostate Cancer Biomarker Product
Table 55. QIAGEN Revenue in Prostate Cancer Biomarker Business (2018-2023) & (US$ Million)
Table 56. QIAGEN Recent Development
Table 57. Roche Diagnostics Company Detail
Table 58. Roche Diagnostics Business Overview
Table 59. Roche Diagnostics Prostate Cancer Biomarker Product
Table 60. Roche Diagnostics Revenue in Prostate Cancer Biomarker Business (2018-2023) & (US$ Million)
Table 61. Roche Diagnostics Recent Development
Table 62. Beckman Coulter Company Detail
Table 63. Beckman Coulter Business Overview
Table 64. Beckman Coulter Prostate Cancer Biomarker Product
Table 65. Beckman Coulter Revenue in Prostate Cancer Biomarker Business (2018-2023) & (US$ Million)
Table 66. Beckman Coulter Recent Development
Table 67. Myriad Genetics Company Detail
Table 68. Myriad Genetics Business Overview
Table 69. Myriad Genetics Prostate Cancer Biomarker Product
Table 70. Myriad Genetics Revenue in Prostate Cancer Biomarker Business (2018-2023) & (US$ Million)
Table 71. Myriad Genetics Recent Development
Table 72. Sanofi-Aventis Company Detail
Table 73. Sanofi-Aventis Business Overview
Table 74. Sanofi-Aventis Prostate Cancer Biomarker Product
Table 75. Sanofi-Aventis Revenue in Prostate Cancer Biomarker Business (2018-2023) & (US$ Million)
Table 76. Sanofi-Aventis Recent Development
Table 77. Pfizer Company Detail
Table 78. Pfizer Business Overview
Table 79. Pfizer Prostate Cancer Biomarker Product
Table 80. Pfizer Revenue in Prostate Cancer Biomarker Business (2018-2023) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. MDx Health Company Detail
Table 83. MDx Health Business Overview
Table 84. MDx Health Prostate Cancer Biomarker Product
Table 85. MDx Health Revenue in Prostate Cancer Biomarker Business (2018-2023) & (US$ Million)
Table 86. MDx Health Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Biomarker Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Prostate Cancer Biomarker Market Share by Type: 2022 VS 2033
Figure 3. Urine Features
Figure 4. Blood Features
Figure 5. Serum Features
Figure 6. Global Prostate Cancer Biomarker Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Prostate Cancer Biomarker Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Cancer Institutes Case Studies
Figure 11. Prostate Cancer Biomarker Report Years Considered
Figure 12. Global Prostate Cancer Biomarker Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Prostate Cancer Biomarker Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Prostate Cancer Biomarker Market Share by Region: 2022 VS 2033
Figure 15. Global Prostate Cancer Biomarker Market Share by Players in 2022
Figure 16. Global Top Prostate Cancer Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Biomarker as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Prostate Cancer Biomarker Revenue in 2022
Figure 18. North America Prostate Cancer Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Prostate Cancer Biomarker Market Share by Country (2018-2033)
Figure 20. United States Prostate Cancer Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Prostate Cancer Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Prostate Cancer Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Prostate Cancer Biomarker Market Share by Country (2018-2033)
Figure 24. Germany Prostate Cancer Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Prostate Cancer Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Prostate Cancer Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Prostate Cancer Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Prostate Cancer Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Prostate Cancer Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Prostate Cancer Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Prostate Cancer Biomarker Market Share by Region (2018-2033)
Figure 32. China Prostate Cancer Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Prostate Cancer Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Prostate Cancer Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Prostate Cancer Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Prostate Cancer Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Prostate Cancer Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Prostate Cancer Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Prostate Cancer Biomarker Market Share by Country (2018-2033)
Figure 40. Mexico Prostate Cancer Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Prostate Cancer Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Prostate Cancer Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Prostate Cancer Biomarker Market Share by Country (2018-2033)
Figure 44. Turkey Prostate Cancer Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Prostate Cancer Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Thermo Fisher Scientific Revenue Growth Rate in Prostate Cancer Biomarker Business (2018-2023)
Figure 47. QIAGEN Revenue Growth Rate in Prostate Cancer Biomarker Business (2018-2023)
Figure 48. Roche Diagnostics Revenue Growth Rate in Prostate Cancer Biomarker Business (2018-2023)
Figure 49. Beckman Coulter Revenue Growth Rate in Prostate Cancer Biomarker Business (2018-2023)
Figure 50. Myriad Genetics Revenue Growth Rate in Prostate Cancer Biomarker Business (2018-2023)
Figure 51. Sanofi-Aventis Revenue Growth Rate in Prostate Cancer Biomarker Business (2018-2023)
Figure 52. Pfizer Revenue Growth Rate in Prostate Cancer Biomarker Business (2018-2023)
Figure 53. MDx Health Revenue Growth Rate in Prostate Cancer Biomarker Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed